'김갑성' 기자의 전체기사
-
Elevating Healthcare Innovation: ICP DAS-BMP Brings Advance…
HSINCHU, Sept. 9, 2025 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in Medtec China 2025, to be held from September 24 to 26 at the Shanghai World Expo Exhibition & Convention Center. The spotlight of this year's exhibit will be the low-migration ARP-B20 TPU, developed to meet ISO 10993 biocompatibility standards and suitable for 90-day implant applications. Low-migration TPU significantly reduces additive migration during the heat-setting pr
- 김갑성 기자
- 2025-09-09 09:45
-
의료 혁신의 도약: ICP DAS-BMP, 메디텍 차이나 2025에서 첨단 TPU 포트폴리오 공개
신주 2025년 9월 9일 -- 대만에 본사를 둔 의료용 TPU(열가소성 폴리우레탄)의 제조 및 공급업체인 ICP DAS-BMP(Biomedical Polymers)가 9월 24일부터 26일까지 상하이 세계엑스포전시컨벤션센터(Shanghai World Expo Exhibition & Convention Center )에서 개최되는 메디텍 차이나 2025(Medtec China 2025)에 참가한다고 발표했다. 올해 전시회의 핵심 제품은 내이행성 ARP-B20 TPU로, ISO 10993 생체 적합성 표준을 충족하며 90일간의 체내 이식 분야에 적합하도록 개발됐다. 내이행성 TPU는 열 고정 공정 중 첨가제 이동을 크게 줄여 카테터가 사용 기간 내내 깨끗하고 매끄러운 표면을 유지하도록 돕는다. 15가지 색상 옵션을 제공해 설계 유연성을 높였으며, 특정 임상 요구에 맞는 맞춤형 솔루션 구현이 가능하다. ICP DAS-BMP는 또한 다양한 의료 분야에 활용할 수 있는 다양한 TPU 소재를 선보인다. 기본 Arothane™, Alithane™, Durathane™ TPU(ARP/ALP/ALC 시리즈)는
- 김갑성 기자
- 2025-09-09 09:45
-
Amorepacific Group Marks 80th Anniversary: Unveils New Visio…
- Aims to achieve 70% in overseas sales and rank among the global top three in premium skincare- Declares mid- to long-term strategy to become a global leader in beauty & wellness SEOUL, South Korea, Sept. 9, 2025 -- The Amorepacific group announced a new leap forward to mark its 80th anniversary. At its anniversary ceremony held on September 4, the company unveiled the goal of KRW 15 trillion in group sales by 2035, alongside its mid- to long-term vision and strategies to become a global leader in beauty and wellness. Experience the full interactive Multichannel N
- 김갑성 기자
- 2025-09-09 09:00
-
Leidos Australia launches into Australia-Pacific maritime au…
MELBOURNE, Sept. 8, 2025 -- Leidos has commenced the Australian build of Sea Archer, a next-generation small uncrewed surface vessel (USV). This marks a major step forward in bringing Leidos' proven autonomous technology and maritime systems portfolio to the Indo-Pacific region while supporting AUKUS objectives and the Australian Defence Force's mission needs. The move into local manufacturing of autonomous vessels fast-tracks proven U.S. capability to Australia, harnessing Leidos' 50-year heritage with the U.S. Navy and its record of more than 120,000 fully autonomous nautical
- 김갑성 기자
- 2025-09-09 06:00
-
서텍스, SIR-Spheres® Y-90 수지 미세구체, CE 마크 확대 승인 획득
적응증 확대로 유럽 및 CE 마크 적용 지역에서 간암 치료 접근성 향상 워번, 매사추세츠, 2025년 9월 9일 -- 최소 침습 중재적 종양학 솔루션 분야의 선도 기업인 서텍스 메디컬(Sirtex Medical, 이하 '서텍스')이 9월 8일 간암 환자 치료를 위한 SIR-Spheres® Y-90 수지 미세구체에 대해 CE 마크 확대 승인을 받았다고 발표했다. 이번 승인 확대로 원발성 간암뿐만 아니라 이차성 간 전이 환자도 치료 대상에 포함되어, 이미 확립된 표적 치료를 받을 수 있는 환자 범위가 넓어졌다. 매트 슈미트(Matt Schmidt) 서텍스 메디컬 최고경영자(CEO)는 "이번 성과는 단순한 규제 승인을 넘어, 가장 힘든 암 진단에 직면한 환자들에게 희망과 선택권을 되돌려주는 것"이라며, "SIR-Spheres® 접근성을 확대함으로써 더 많은 환자가 가장 필요할 때 잘 견디는 표적 치료 혜택을 받을 수 있도록 보장한다"라고 말했다. 선택적 내부 방사선 치료(SIRT)로 알려진 방사선색전술은 간 동맥을 통해 이트륨-90을 종양에 직접 전달해, 고용량
- 김갑성 기자
- 2025-09-09 05:31
-
Aechelon and Partners Niantic Spatial, ICEYE, BlackSky and Dis…
Pioneering the Next Era of Live Synthetic Reality—Empowering Global, All-Sensor AI Training Across All Conditions for Human Readiness and Autonomous Systems SOUTH SAN FRANCISCO, Calif., Sept. 9, 2025 -- Aechelon Technology, a global defense leader in geospatial simulation technology and human/machine AI training systems today announced 'Project Orbion' together with its partners. Project Orbion is a groundbreaking new initiative that will integrate best-of-class technology solutions to create a live Digital Twin of the Earth. All of this is complete with accurate physics, real-
- 김갑성 기자
- 2025-09-09 05:20
-
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y…
Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. WOBURN, Mass., Sept. 8, 2025 -- Sirtex Medical ("Sirtex"), a leading manufacturer of minimally invasive interventional oncology solutions, today announced that it has received an expanded CE Mark approval for SIR-Spheres® Y-90 resin microspheres for the treatment of patients with liver cancer. With this expansion, eligibility now covers both primary and secondary liver metastases, increasing patient access to a well-established, targeted therapy. "T
- 김갑성 기자
- 2025-09-08 21:00
-
Nobel Laureate Headlines Global Discussion in Cell & Gene…
PISCATAWAY, N.J., Sept. 8, 2025 -- Cell and gene therapies (CGT) are advancing rapidly and are reshaping the future of medicine. From CRISPR-based genome editing to new applications of in vivo and ex vivo cell therapies, scientific breakthroughs are increasingly moving from the laboratory into clinical practice. At the same time, global investment and innovation in the field are accelerating, positioning CGT as one of the fastest-growing areas in life sciences. One of the greatest challenges for the industry lies in translating these advances into lasting patient benefits and sustainab
- 김갑성 기자
- 2025-09-08 20:49
-
SpaceGut's Precision AI System for Gut Testing Achieves Up to…
KUALA LUMPUR, Malaysia, Sept. 8, 2025 -- SpaceGut, Malaysia's first AI-powered at-home Gut Microbiome Test Kit, has paved the way for users to take control of their digestive wellness and conditions such as Irritable Bowel Syndrome (IBS) from home. In the 10 months since it was launched, its breakthrough AI-powered gut health testing has been used by more than 500 individuals to extract tailored insights and solutions for improving their gut health and alleviating digestive conditions like IBS. In Malaysia, approximately 14% of the population is affected by IBS, with many facin
- 김갑성 기자
- 2025-09-08 20:37
-
Medit Expands Orthodontic Suite with Launch of Medit Aligne…
NEWPORT BEACH, Calif., Sept. 8, 2025 -- Medit, a global leader in digital dentistry solutions, today announced the launch of Medit Aligners, a premium digital clear aligner solution designed to deliver faster turnaround times and more predictable outcomes for orthodontic patients. Medit Aligners integrate seamlessly with the Medit Orthodontic Suite (MOS), giving orthodontists the ability to simulate, design, and refine treatment plans before sending them directly into production. The result: a flexible, efficient workflow that combines clinical control with world-
- 김갑성 기자
- 2025-09-08 20:30
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-22_WED
2025-10-21_TUE
- AESOP Technology announces DxPrime is now a qualified solution on Mayo Clinic Platform 23:30
- Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq 23:00
- Stéphane Rolland's Haute Couture to Illuminate the 10th Anniversary of Barcelona Bridal Night 23:00
- JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène 22:00
- AI meets capital: Bizcap welcomes 8fig into its global portfolio to accelerate growth funding 22:00
- Youth Innovation Safeguards Green Heritage: 2025 World Food Forum Youth Action on Green Agri-Heritage Held in Rome 21:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 22일 03시 00분